Kerala, international scientists develop transgenic rice

2018-10-26 09:56:07

Researchers from Jawaharlal Nehru University, International Centre for Genetic Engineering and Biotechnology and University of Illinois have developed transgenic rice that promises to generate high yields even under conditions of high salinity, high temperature and drought.By Team ABLEA group of researchers from Jawaharlal Nehru University (JNU), International Centre for Genetic Engineering and Bi

Read more

Mitra Biotech advances development of next-generation cancer immunotherapies

2018-10-26 09:55:09

To better understand how oncolytic viruses work in cancer patients, Brigham and Women\'s Hospital will leverage Mitra\'s CANscript platform to study their biological mechanisms of actionBy Team ABLEBengaluru-located Mitra Biotech has announced a collaborative research partnership with Brigham and Women\'s Hospital and the Department of Neurosurgery to further transform personalized immuno-oncology

Read more

IEEE announces forum on Blockchain for clinical trials

2018-10-25 09:54:47

The Forum would provide updates on the progress of pilots and implementation of blockchain technology into clinical trialsBy Team ABLEIEEE, the world\'s largest technical professional organization dedicated to advancing technology for humanity, and the IEEE Standards Association (IEEE-SA), has announced details of the upcoming second edition of The IEEE Blockchain for Clinical Trials Forum to be h

Read more

Baylor researchers awarded grant to develop diabetes mobile health app for use in India

2018-10-25 09:52:49

Baylor University researchers and physicians from Bangalore Baptist Hospital were awarded a 21st Century Knowledge Initiative Grant from the U.S. India Education Foundation (USIEF) to develop a diabetes mobile health app to boost awareness on diabetes.By Team ABLEAn interdisciplinary team of Baylor University researchers – from nursing and business information systems to art and video game desig

Read more

FDA approves new drug to treat influenza

2018-10-25 09:51:10

This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 yearsBy Team ABLEThe US Food and Drug Administration approved Xofluza (baloxavirmarboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.The FDA granted approval of Xofluza to Shionogi &am

Read more

NANOBIOTECK- 2018 conference sets stage for interdisciplinary interactions in nanobiotechnology

2018-10-25 09:41:50

NANOBIOTECK- 2018 is being organized by the Indian Society of Nanomedicine (ISNM) at All India Institute of Medical Sciences from 24th - 27th October, 2018.By Team ABLENANOBIOTECK-2018 is jointly hosted by All India Institute of Medical Sciences, New Delhi and Indian Institute of Technology, New Delhi in partnership with the Department of Biotechnology and the Department of Science & Technolog

Read more

Bain Capital, Pfizer create Cerevel Therapeutics dedicated to CNS clinical compounds

2018-10-25 08:05:14

It is believed that Pfizer had felt that placing a set of neuroscience assets in a company with dedicated focus and expertise in CNS was the optimal next step.By Team ABLEBain Capital LP and Pfizer Inc. have announced the creation of Cerevel Therapeutics LLC, a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system (CNS). Pfizer is cont

Read more

IAVI, Serum Institute collaborate to develop optimal combination of affordable HIV-specific antibodies

2018-10-23 05:47:35

Serum Institute and IAVI have joined forces in the fight against HIV with the aim of making cost-effective monoclonal antibodies for HIV.By Team ABLEThe International AIDS Vaccine Initiative (IAVI) and Serum Institute of India, the world\'s largest vaccine manufacturer, has announced a strategic partnership to develop and manufacture affordable and accessible monoclonal antibody products for HIV a

Read more

Merck to Sell Amnis Flow Cytometry and Guava Technologies businesses to Luminex Corporation

2018-10-22 07:49:06

With this acquisition from Merck, Luminex aims to increase footprint in the multi-billion-dollar flow cytometry market. By Team ABLEWorld’s oldest science and technology company,Merck has signed a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for €62.5 million.Upon completion of the transaction, Luminex will own the flow cytometry platforms Amnisand Guava and

Read more

IISC-incubated biotech startup Mynvax secures angel funding

2018-10-22 07:42:21

Mynvax Pvt Ltd, a biotech startup, has raised its angel round of funding from prominent investors. By Team ABLEMynvax, the Indian Institute of Science-incubated biotech startups, was founded in 2017 by Raghavan Varadarajan and Gautham Nadig. The company, which is in research mode at present, develops next-generation vaccines for influenza using a recombinant technology that will be used to cr

Read more